Quantitative assessment of optic nerve changes in patients with diabetic macular edema treated with fluocinolone acetonide vitreous implants

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 47, Issue 5, 2016, Pages 418-425

  Parrish, Richard K ^a   Traverso, Carlo E ^b   Green, Ken ^c   Danis, Ronald P ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c Alimera Sciences Limited   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUOCINOLONE ACETONIDE; HEMOGLOBIN A1C; VASCULOTROPIN INHIBITOR; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DISC HEMORRHAGE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENTION TO TREAT ANALYSIS; INTRAOCULAR HEMORRHAGE; INTRAVITREAL IMPLANT; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTIC NERVE; OPTIC NERVE DISEASE; PALLOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY; COMPLICATION; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFECTS; DRUG IMPLANT; MACULAR EDEMA; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; TREATMENT OUTCOME; VERY ELDERLY; VITREOUS BODY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC RETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; OPTIC NERVE; OUTCOME ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY; YOUNG ADULT;

EID: 84983414669     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20160419-04     Document Type: Article

References (14)

1. Campochiaro PA, Brown DM, Pearson A, et al. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology. 2011;118(4):626-635.e2.
2. Iluvien (fluocinolone acetonide intravitreal implant) [package insert]. Alpharetta, GA: Alimera Sciences; 2014.
3. Campochiaro PA, Brown DM, Pearson A, et al. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012;119(10):2125-2132.
4. Alimera Sciences F. UK ILUVIEN Summary of Product Characteristics. https://www.medicines.org.uk/emc/medicine/27636. Updated 2013. Accessed September 25, 2013.
5. Schwartz SG, Flynn HW Jr., Scott IU. Intravitreal corticosteroids in the management of diabetic macular edema. Curr Ophthalmol Rep. 2013;1(3). doi:10.1007/s40135-013-0015-3.
6. Ungar AK, Wollstein G, Ishikawa H, et al. Evaluating objective and subjective quantitative parameters at the initial visit to predict future glaucomatous visual field progression. Ophthalmic Surg Lasers Imaging. 2012;43(5):416-424.
7. Garway-Heath DF, Ruben ST, Viswanathan A, Hitchings RA. Vertical cup/disc ratio in relation to optic disc size: its value in the assessment of the glaucoma suspect. Br J Ophthalmol. 1998;82(10):1118-1124.
8. Tatham AJ, Weinreb RN, Zangwill LM, Liebmann JM, Girkin CA, Medeiros FA. The relationship between cup-to-disc ratio and estimated number of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2013;54(5):3205-3214.
9. Hayreh SS. Pathogenesis of cupping of the optic disc. Br J Ophthalmol. 1974;58(10):863-876.
10. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology. 1979;86(10):1803-1830.
11. Feuer WJ, Parrish RK II, Schiffman JC, et al. The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center. Am J Ophthalmol. 2002;133(1):19-28.
12. Abrams LS, Scott IU, Spaeth GL, Quigley HA, Varma R. Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology. 1994;101(10):1662-1667.
13. Varma R, Spaeth GL, Steinmann WC, Katz LJ. Agreement between clinicians and an image analyzer in estimating cup-to-disc ratios. Arch Ophthalmol. 1989;107(4):526-529.
14. Tielsch JM, Katz J, Quigley HA, Miller NR, Sommer A. Intraobserver and interobserver agreement in measurement of optic disc characteristics. Ophthalmology. 1988;95(3):350-356.